
Edward Robinson
1.6K posts

Edward Robinson
@edwardlabs
Oncology researcher, gardening enthusiast 🌱, and proud dog dad 🐾



Competition on Trop2 ADC is fierce and a crowded area. The other widely expressed target is B7H3. $MRK molecule there causes higher ILD and will lose long term. It is in SCLC , prostate , NSCLC , esophagus , sarcoma , pancreas etc. They need to find an alternative






My letter in today's Toronto Star:


Pleasant Surprise from #ASCO26 Abstract 8002 (LORIN): neoadjuvant lorlatinib in stage III ALK+ NSCLC hits a pCR of 46.9% and MPR of 81.3% — pathologic responses we rarely see with neoadjuvant TKIs. 75% of initially unresectable pts converted to surgery. Targeted neoadj earning its seat. #LCSM @OncoAlert @OncBrothers @StephenVLiu @Jani_Chinmay @asco @myESMO @glopesmd @SylvesterCancer @latinamd @COlazagasti



#NEW: University Ave. should be a hospital corridor first, not a traffic experiment. We are calling for removal of bike lanes that slow ambulance access to Canada’s busiest hospitals. Sign the petition. Share this post. abctoronto.org/petitions/bike… #TOpoli #Toronto

What’s the harshest truth every young man must eventually learn?











Dear Colleagues, As #ASCO26 descends on Chicago, @OncoAlert 🚨 is proud to introduce the OncoAlert PULSE Faculty 🩺 — your frontline team for every breakthrough, every result, every moment. Live. As it happens. @DrChoueiri 🇺🇸 @hoperugo 🇺🇸 @matteolambe 🇮🇹 @TiansterZhang 🇺🇸 @cdanicas 🇪🇸 @NiuSanford 🇺🇸 @amerseburger 🇩🇪 @GlopesMd 🇺🇸 @Icro_Meattini 🇮🇹 @PGrivasMDPhD 🇺🇸 @DrYukselUrun 🇹🇷 @nataliagandur 🇦🇷 @ElisaAgostinett 🇧🇪 @HHorinouchi 🇯🇵 @realbowtiedoc 🇺🇸 @to_be_elizabeth 🇮🇹 @UOzkerim🇹🇷 @p_ciracimd 🇮🇹 @DrVilmaPBarcia 🇪🇸 @DraMartinezLago @GaiaGriguolo 🇮🇹 @MarioBalsaMD 🇪🇸 @scocmem 🇬🇧 @AmandaNizamMD 🇺🇸 & @weoncologists 🇺🇸




